| James Hansen, DO | |
|
315 W State St, Doylestown, PA 18901-3525 | |
| (215) 345-1900 | |
| (215) 345-4579 |
| Full Name | James Hansen |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 15 Years |
| Location | 315 W State St, Doylestown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275769846 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Doylestown Hospital | Doylestown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Via Affiliates | 1759295512 | 182 |
News Archive
Scientists have long sought the ability to regenerate nerve cells, or neurons, which could offer a new way to treat spinal-cord damage as well as neurological diseases such as Alzheimer's or Parkinson's. Many chemicals can regenerate neurons grown in Petri dishes in the lab, but it's difficult and time-consuming to identify those chemicals that work in live animals, which is critical for developing drugs for humans.
NeurAxon, Inc., a development-stage pharmaceutical company that is designing and developing next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), today announced that it has closed a convertible debenture financing in which the convertible debentures are convertible under specified circumstances into existing class B preferred shares for a total of approximately $14 million.
NanoBio Corporation announced today it will present data from three preclinical studies at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium taking place from Sept. 27-30 in Santa Fe, N.M.
The International Contrast Ultrasound Society (ICUS) today applauded the FDA's decision to modify the U.S. product label for OPTISON, an ultrasound contrast agent used to improve the accuracy of radiation-free ultrasound scans.
› Verified 3 days ago
| Entity Name | Via Affiliates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003446261 PECOS PAC ID: 1759295512 Enrollment ID: O20031117000104 |
News Archive
Scientists have long sought the ability to regenerate nerve cells, or neurons, which could offer a new way to treat spinal-cord damage as well as neurological diseases such as Alzheimer's or Parkinson's. Many chemicals can regenerate neurons grown in Petri dishes in the lab, but it's difficult and time-consuming to identify those chemicals that work in live animals, which is critical for developing drugs for humans.
NeurAxon, Inc., a development-stage pharmaceutical company that is designing and developing next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), today announced that it has closed a convertible debenture financing in which the convertible debentures are convertible under specified circumstances into existing class B preferred shares for a total of approximately $14 million.
NanoBio Corporation announced today it will present data from three preclinical studies at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium taking place from Sept. 27-30 in Santa Fe, N.M.
The International Contrast Ultrasound Society (ICUS) today applauded the FDA's decision to modify the U.S. product label for OPTISON, an ultrasound contrast agent used to improve the accuracy of radiation-free ultrasound scans.
› Verified 3 days ago
| Entity Name | St Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
Scientists have long sought the ability to regenerate nerve cells, or neurons, which could offer a new way to treat spinal-cord damage as well as neurological diseases such as Alzheimer's or Parkinson's. Many chemicals can regenerate neurons grown in Petri dishes in the lab, but it's difficult and time-consuming to identify those chemicals that work in live animals, which is critical for developing drugs for humans.
NeurAxon, Inc., a development-stage pharmaceutical company that is designing and developing next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), today announced that it has closed a convertible debenture financing in which the convertible debentures are convertible under specified circumstances into existing class B preferred shares for a total of approximately $14 million.
NanoBio Corporation announced today it will present data from three preclinical studies at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium taking place from Sept. 27-30 in Santa Fe, N.M.
The International Contrast Ultrasound Society (ICUS) today applauded the FDA's decision to modify the U.S. product label for OPTISON, an ultrasound contrast agent used to improve the accuracy of radiation-free ultrasound scans.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Hansen, DO Po Box 8298641, Philadelphia, PA 19182-9641 Ph: (267) 370-5296 | James Hansen, DO 315 W State St, Doylestown, PA 18901-3525 Ph: (215) 345-1900 |
News Archive
Scientists have long sought the ability to regenerate nerve cells, or neurons, which could offer a new way to treat spinal-cord damage as well as neurological diseases such as Alzheimer's or Parkinson's. Many chemicals can regenerate neurons grown in Petri dishes in the lab, but it's difficult and time-consuming to identify those chemicals that work in live animals, which is critical for developing drugs for humans.
NeurAxon, Inc., a development-stage pharmaceutical company that is designing and developing next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), today announced that it has closed a convertible debenture financing in which the convertible debentures are convertible under specified circumstances into existing class B preferred shares for a total of approximately $14 million.
NanoBio Corporation announced today it will present data from three preclinical studies at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium taking place from Sept. 27-30 in Santa Fe, N.M.
The International Contrast Ultrasound Society (ICUS) today applauded the FDA's decision to modify the U.S. product label for OPTISON, an ultrasound contrast agent used to improve the accuracy of radiation-free ultrasound scans.
› Verified 3 days ago
Andrew E Krick, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 310 Farm Lane, Doylestown, PA 18901 Phone: 215-348-3990 Fax: 215-348-7705 | |
Sherilyn Lisa Tittermary Mccollum, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1456 Ferry Road, Suite 403, Doylestown, PA 18901 Phone: 267-483-8094 Fax: 267-483-8312 | |
Dr. George Wiemann, M.D, FACC Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 315 W State St, Doylestown, PA 18901 Phone: 215-345-1900 Fax: 215-345-4579 | |
Marvin Ralph Gordon, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 4740 Dickinson Way, Doylestown, PA 18902 Phone: 215-794-2528 Fax: 267-544-0105 | |
Christopher P Hermann, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301s Main St, Ste 2w, Doylestown, PA 18901 Phone: 215-348-4800 Fax: 215-348-4350 | |
Mr. Les A Szekely, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2003 Lower State Rd Unit 110, Doylestown, PA 18901 Phone: 215-348-1310 Fax: 215-348-8615 | |
Venu Pasricha, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 595 W State St, Doylestown, PA 18901 Phone: 215-345-2885 Fax: 215-345-2552 |